9 May 2016 - At the age of 36, Danielle Tindle has been given an ultimatum — your money or your life.

A decade after surviving Hodgkin's lymphoma, Dr Tindle is critically ill with another rare cancer.

But this time, she is being forced to pay thousands of dollars for potentially life-saving drugs which are available at minimal cost to other patients under the Pharmaceutical Benefits Scheme (PBS).

When Dr Tindle gets her immunotherapy for cancer every two weeks, it costs her nearly $5,000 a shot.

In the private hospital cubicle next to her could be a melanoma patient who is paying just $6.20 per treatment.

The discrepancy is due to drug listing requirements for the PBS.

For more details, go to: http://www.abc.net.au/news/2016-05-09/rare-cancer-patient-dealt-'unfair'-drug-costs/7391874